Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan

Early detection and accurate monitoring of chronic kidney disease (CKD) could improve care and retard progression to end-stage renal disease. Here, using untargeted metabolomics in 2155 participants including patients with stage 1–5 CKD and healthy controls, we identify five metabolites, including 5...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Dan-Qian, Cao, Gang, Chen, Hua, Argyopoulos, Christos P., Yu, Hui, Su, Wei, Chen, Lin, Samuels, David C., Zhuang, Shougang, Bayliss, George P., Zhao, Shilin, Yu, Xiao-Yong, Vaziri, Nosratola D., Wang, Ming, Liu, Dan, Mao, Jia-Rong, Ma, Shi-Xing, Zhao, Jin, Zhang, Yuan, Shang, You-Quan, Kang, Huining, Ye, Fei, Cheng, Xiao-Hong, Li, Xiang-Ri, Zhang, Li, Meng, Mei-Xia, Guo, Yan, Zhao, Ying-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443780/
https://www.ncbi.nlm.nih.gov/pubmed/30931940
http://dx.doi.org/10.1038/s41467-019-09329-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443780/
https://www.ncbi.nlm.nih.gov/pubmed/30931940
http://dx.doi.org/10.1038/s41467-019-09329-0

Ejemplares similares